Skip to main content
TipRanks
Go Ultimate75% OFF

Zhongzhi Pharmaceutical Holdings Limited (3737) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Zhongzhi Pharmaceutical Holdings Limited has a market cap or net worth of HKD 567.49M. The enterprise value is HKD 588.70M.

Market Cap
HKD 567.49M
Enterprise Value
HKD 588.70M

Share Statistics

Zhongzhi Pharmaceutical Holdings Limited has 863,600,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
863,600,000
Owned by Insiders
―
Owned by Institutions
<0.01%

Financial Efficiency

Zhongzhi Pharmaceutical Holdings Limited’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 0.34%.

Return on Equity (ROE)
0.02
Return on Assets (ROA)
0.01
Return on Invested Capital (ROIC)
0.34%
Return on Capital Employed (ROCE)
0.00
Revenue Per Employee
801.42K
Profits Per Employee
7,975.092
Employee Count
2,168
Asset Turnover
0.95
Inventory Turnover
2.84

Valuation Ratios

The current PE Ratio of Zhongzhi Pharmaceutical Holdings Limited is 26.70. Zhongzhi Pharmaceutical Holdings Limited’s PEG ratio is -2.85.

PE Ratio
26.70
PS Ratio
0.29
PB Ratio
0.44
Price to FCF
7.53
Price to Operating Cash Flow
5.07
PEG Ratio
-2.85

Income Statement

In the last 12 months, Zhongzhi Pharmaceutical Holdings Limited had revenue of 1.74B and earned 17.29M in profits. Earnings per share was 0.02.

Revenue
1.74B
Gross Profit
940.25M
Operating Income
4.93M
Pretax Income
18.99M
Net Income
17.29M
EBITDA
99.81M
Earnings Per Share (EPS)
0.02

Cash Flow

In the last 12 months, operating cash flow was 94.71M and capital expenditures -30.94M, giving a free cash flow of 63.77M billion.

Operating Cash Flow
94.71M
Free Cash Flow
63.77M
Free Cash Flow per Share
0.08

Dividends & Yields

Zhongzhi Pharmaceutical Holdings Limited pays an annual dividend of HKD 0.05, resulting in a dividend yield of 7.46%

Dividend Per Share
HKD 0.05
Dividend Yield
7.46%
Payout Ratio
N/A
Free Cash Flow Yield
13.29%
Earnings Yield
3.67%

Stock Price Statistics

Beta
0.06
52-Week Price Change
11.67%
50-Day Moving Average
0.69
200-Day Moving Average
0.73
Relative Strength Index (RSI)
54.13
Average Volume (3m)
394.63K

Important Dates

Zhongzhi Pharmaceutical Holdings Limited upcoming earnings date is Mar 25, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 26, 2026
Next Earnings Date
Mar 25, 2027
Ex-Dividend Date
May 23, 2025

Financial Position

Zhongzhi Pharmaceutical Holdings Limited as a current ratio of 1.60, with Debt / Equity ratio of 20.73%

Current Ratio
1.60
Quick Ratio
1.15
Debt to Market Cap
0.46
Net Debt to EBITDA
0.26
Interest Coverage Ratio
0.94

Taxes

In the past 12 months, Zhongzhi Pharmaceutical Holdings Limited has paid 1.28M in taxes.

Income Tax
1.28M
Effective Tax Rate
0.07

Enterprise Valuation

Zhongzhi Pharmaceutical Holdings Limited EV to EBITDA ratio is 3.61, with an EV/FCF ratio of 6.37.

EV to Sales
0.25
EV to EBITDA
3.61
EV to Free Cash Flow
6.37
EV to Operating Cash Flow
4.29

Balance Sheet

Zhongzhi Pharmaceutical Holdings Limited has HKD 185.38M in cash and marketable securities with HKD 87.63M in debt, giving a net cash position of HKD 97.75M billion.

Cash & Marketable Securities
HKD 185.38M
Total Debt
HKD 87.63M
Net Cash
HKD 97.75M
Net Cash Per Share
HKD 0.11
Tangible Book Value Per Share
HKD 1.30

Margins

Gross margin is 53.18%, with operating margin of 0.96%, and net profit margin of 1.07%.

Gross Margin
53.18%
Operating Margin
0.96%
Pretax Margin
1.94%
Net Profit Margin
1.07%
EBITDA Margin
6.83%
EBIT Margin
0.66%

Analyst Forecast

The average price target for Zhongzhi Pharmaceutical Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-15.17%
EPS Growth Forecast
-11.41%

Scores

Smart Score
6
AI Score
61